HomeAI · summaries
Storia in 5 fonti
Curium strikes up to $8B deal for radiopharma rival Lantheus
Months after reports first linked Curium to a potential Lantheus takeover, the radiopharma players have made it official with a deal worth up to $8 billion. | Months after reports first linked Curium to a potential Lantheus takeover, the radiopharma players have made it official with a deal worth up to $8 billion.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Curium buys Lantheus for $8B; Sandoz settles price-fixing cases
Curium acquires Lantheus for $102.5/share (~$8B); Sandoz settles price-fixing for $478.5M; Latigo eyes $247M IPO for non-opioid LTG-001; BlossomHill targets $111M IPO.
- ·
lecho.be
Dirigée par le Belge Renaud Dehareng, Curium Pharma rachète Lantheus pour 8 milliards de dollars
La société Curium Pharma spécialisée dans la radiothérapie vient d'annoncer le rachat de Lantheus, un autre acteur du secteur. Avec cette acquisition, la nouvelle structure…
